Figure 3.

Treatment-emergent adverse events in the TEMSO trial: relative risk versus placebo.

Treatment-emergent adverse events ≥ 10% in any group by MedDRA-preferred term ranked by decreasing order of relative risk versus placebo. MedDRA-preferred term for hair thinning/decreased hair density: alopecia. The term ‘alopecia’ is used to describe any type of hair loss. Most cases of alopecia were reported as hair thinning, decreased hair density, or hair loss.

(Adapted from Miller et al. [2011].)

ALT, alanine aminotransferase; CI, confidence interval; MedDRA, Medical Dictionary for Regulatory Activities.